Network Deputy Director, Biomarker & Discovery Research
Laurence Turka, MD, is a Professor of Surgery (part-time) at Harvard Medical School and Massachusetts General Hospital. He is an internationally recognized expert in the areas of immune tolerance and transplantation immunology. His contributions include pioneering work in the areas of the use of costimulatory blockade to induce transplantation tolerance, the role of deletion in the induction of peripheral tolerance and the barrier to tolerance which is created by non-specific T cell deletion. Dr. Turka currently serves as the Chief Scientific Officer and Head of Early Development of Rheos Medicines, a company studying the metabolism of immune cells as a means to develop new treatments for autoimmune diseases.
Dr. Turka has been involved in the Immune Tolerance Network since its inception, and is currently the Deputy Director for Biomarker & Discovery Research, a member of the Network Steering Committee and the Network Executive Committee and Chair of the Drug Withdrawal Committee. He is a past-President of the American Society of Transplantation, and past Chair of the NIAID Board of Scientific Counselors.